These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8290376)

  • 21. Screening for carriers of cystic fibrosis--a general practitioner's perspective.
    Modell M
    BMJ; 1993 Oct; 307(6908):849-52. PubMed ID: 8401130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antenatal screening for cystic fibrosis.
    Cuckle H; Quirke P; Sehmi I; Lewis F; Murray J; Cross D; Cuckle P; Ozols B
    Br J Obstet Gynaecol; 1996 Aug; 103(8):795-9. PubMed ID: 8760710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members.
    Maxwell SJ; Kyne G; Molster C; Barker NM; Ormsby J; O'Leary P
    Genet Test Mol Biomarkers; 2011 Mar; 15(3):159-64. PubMed ID: 21204697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in psychosocial reactions to cystic fibrosis carrier testing.
    Newman JE; Sorenson JR; DeVellis BM; Cheuvront B
    Am J Med Genet; 2002 Nov; 113(2):151-7. PubMed ID: 12407705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal cystic fibrosis carrier screening: factors in a woman's decision to decline testing.
    Mennie ME; Gilfillan A; Compton ME; Liston WA; Brock DJ
    Prenat Diagn; 1993 Sep; 13(9):807-14. PubMed ID: 8278311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carrier screening for cystic fibrosis in a prenatal setting.
    Delvaux I; van Tongerloo A; Messiaen L; Van Loon C; De Bie S; Mortier G; De Paepe A
    Genet Test; 2001; 5(2):117-25. PubMed ID: 11551097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the public.
    Watson EK; Williamson R; Chapple J
    Br J Gen Pract; 1991 Jun; 41(347):237-40. PubMed ID: 1931202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender.
    Marteau TM; Dundas R; Axworthy D
    Health Psychol; 1997 Jan; 16(1):51-62. PubMed ID: 9028815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales Cystic Fibrosis Carrier Screening Research Team.
    Payne Y; Williams M; Cheadle J; Stott NC; Rowlands M; Shickle D; West G; Meredith L; Goodchild M; Harper PS; Clarke A
    Clin Genet; 1997 Mar; 51(3):153-63. PubMed ID: 9137879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of population based screening for carriers of cystic fibrosis.
    Bekker H; Denniss G; Modell M; Bobrow M; Marteau T
    J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carrier screening for cystic fibrosis: a pilot study of the attitudes of pregnant women.
    Botkin JR; Alemagno S
    Am J Public Health; 1992 May; 82(5):723-5. PubMed ID: 1566951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.
    Grody WW; Dunkel-Schetter C; Tatsugawa ZH; Fox MA; Fang CY; Cantor RM; Novak JM; Bass HN; Crandall BF
    Am J Hum Genet; 1997 Apr; 60(4):935-47. PubMed ID: 9106541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
    Lewis S; Curnow L; Ross M; Massie J
    J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cystic fibrosis gene: medical and social implications for heterozygote detection.
    Wilfond BS; Fost N
    JAMA; 1990 May 23-30; 263(10):2777-83. PubMed ID: 11653890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based genetic screening for cystic fibrosis: attitudes and outcomes.
    Ioannou L; Massie J; Collins V; McClaren B; Delatycki MB
    Public Health Genomics; 2010; 13(7-8):449-56. PubMed ID: 20090299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF).
    Henneman L; Bramsen I; Van Os TA; Reuling IE; Heyerman HG; van der Laag J; van der Ploeg HM; ten Kate LP
    Prenat Diagn; 2001 Jan; 21(1):1-9. PubMed ID: 11180232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    Br J Gen Pract; 1996 Apr; 46(405):225-7. PubMed ID: 8703524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological and social consequences of community carrier screening programme for cystic fibrosis.
    Watson EK; Mayall ES; Lamb J; Chapple J; Williamson R
    Lancet; 1992 Jul; 340(8813):217-20. PubMed ID: 1353144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.